As a valued Morning Consult subscriber, your feedback is critical to Morning Consult’s product development. We’d like to ask five short questions about your experience with Morning Consult’s news and analysis: Take the survey now.
The Food and Drug Administration plans to force Juul Labs Inc. to remove its e-cigarettes from the U.S. market after a nearly two-year review of the vaping giant’s data, people familiar with the matter said, with an announcement expected as soon as this week. The decision would mark a departure from the agency’s stance toward Juul’s biggest rivals, which have been allowed to keep selling tobacco-flavored e-cigarettes. (The Wall Street Journal)
The Biden administration said it will expand commercial lab testing for monkeypox in an effort to curb the country’s outbreak, which health officials warn could be far greater than the official tally of 156 cases. (The Washington Post) The move comes as a World Health Organization panel meets to consider declaring the international outbreak a global emergency, which would give monkeypox the same distinction as COVID-19. (The Associated Press)
The House passed a bill to create the Advanced Research Projects Agency for Health, which Congress has already allocated $1 billion to establish. The White House said it strongly supports the House bill but expressed concerns about some measures, indicating the debate over how the new biomedical research agency should be structured isn’t over yet. (Bloomberg Law)
More than 1 in 3 U.S. adults who have had COVID-19 experienced lingering symptoms for at least three months, according to new federal data that indicates 19% of these adults currently have long COVID symptoms. The study, which also suggests women are more likely than men to report long-term symptoms, could have implications for health care and disability costs, as well as the broader workforce. (Bloomberg)
Top Trump administration officials ignored warnings and embraced a “herd immunity via mass infection” approach to containing COVID-19 to justify not taking meaningful action to curb the virus in the fall and winter of 2020-2021, a House oversight panel report concluded Tuesday.
Moderna Inc.’s omicron-targeting vaccine triggered the production of antibodies against the strain’s newest variants, though the immune response was less robust than seen with the original version that emerged late last year.
COVID-19 vaccines that specifically target the Omicron and other variants are under development, Pfizer Inc’s chief executive said on Wednesday, adding that the company will be able to quickly adapt shots as the novel coronavirus mutates.
Omicron subvariants BA.4 and BA.5 appear to escape antibody responses among both people who had previous Covid-19 infection and those who have been fully vaccinated and boosted, according to new data from researchers at Beth Israel Deaconess Medical Center, of Harvard Medical School.
The United States has delivered about 2.7 million doses of COVID vaccines for children below five years to administration centers while another one million shots will reach the sites soon, the Department of Health and Human Services said on Wednesday.
In wealthy countries, robust public health campaigns together with tighter scrutiny on corporate advertising mean mothers face better chances at making informed decisions about when to use milk formula.
Socioeconomic, racial and gender inequities in healthcare account for nearly $320 billion in annual spending, and could account for $1 trillion or more by 2040, according to an analysis out Wednesday from Deloitte.
The owner of seven Louisiana nursing homes whose residents suffered in squalid conditions after being evacuated to a warehouse as Hurricane Ida approached last year was arrested on Wednesday, Louisiana Attorney General Jeff Landry announced.
A targeted oral drug combination by Novartis won U.S. approval for use in a wide range of advanced solid tumors that are driven by a certain genetic contributor, widening the use of a novel treatment approach that is known as tumor agnostic.
Canada approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis last week. Now some U.S. patients with the fatal neurodegenerative disorder—also known as Lou Gehrig’s disease—are considering a trip north to get the medication, Albrioza.
There are now dozens of groups in operation, and earlier this month, one of them attracted a top biotech VC as a lead investor — a significant milestone that DeSci proponents say will help the field be taken seriously.
A Message From Better Medicare Alliance:
In communities across the country, more seniors are making an active choice for the quality, affordable, coordinated coverage found in Medicare Advantage. In fact, Medicare Advantage exceeds half of all Medicare enrollment in more than 120 Congressional districts nationwide. Better Medicare Alliance’s interactive Medicare Advantage Enrollment Map lets you pinpoint MA enrollment rates by state, Congressional district, and even by county. Check it out for yourself here.
When Stephen Friend left Apple in 2017 after a stint helping to jumpstart its health efforts, the company’s marketing engine was already promoting a future that hadn’t arrived: Apple devices were going to help you live a healthier life.
The Department of Veterans Affairs (VA) will push off deployment of a new electronic medical records system to additional medical facilities until 2023 to address outages that have plagued the software at current sites.
As of December 31, 2020, CMS had approved 201 distinct directed payment arrangements (excluding those related to COVID-19) in 37 states. This was a substantial increase over the 65 distinct arrangements approved in 23 states as of August 2018.